Dr. Martin Salia has passed away as a result of the advanced symptoms of the disease. Salia, 44, arrived Sunday by plane from West Africa. He was in serious condition. He received, in Nebraska, the experimental drug ZMapp and a plasma transfusion from an Ebola survivor. “We used every possible treatment available to give Dr. Salia every possible opportunity for survival,” Dr. Phil Smith, medical director of the biocontainment unit said in a statement released Monday.
What was proved without any doubt is the fact that early treatment with Ebola patients is essential. Dr. Salia, a Sierra Leone citizen, was a permanent resident of the U.S. and lived in Maryland. He had been working as a general surgeon at Kissy United Methodist Hospital in the Sierra Leone capital and worked in at least three other facilities.The source of his infection is not known. The medical team at Nebraska Medical Center saved the lives of two previous patients.
